Macrae FA 1, Good N 3, Young GP, Bampton P 2, Lane J 2, St John DJB 1, Diehl R 3, J O Dwyer 3, Slattery M 1.
|
|
- Charles Wilkerson
- 8 years ago
- Views:
Transcription
1 Macrae FA 1, Good N 3, Young GP, Bampton P 2, Lane J 2, St John DJB 1, Diehl R 3, J O Dwyer 3, Slattery M 1. Colorectal Medicine and Genetics, and University of Melbourne Dept of Medicine The Royal Melbourne Hospital 1, Flinders Centre for Cancer Prevention and Control, Flinders University, Adelaide 2, CSIRO phealth Flagship, Adelaide 3 Australia
2 Introduction International guidelines recognize age of onset and multiplicity of colorectal cancers on the same side of the family as risk factors for familial colorectal cancer. Information on screening outcomes where CRC is present on both sides of the family is unavailable and would be explicable in a recessive model of inheritance. We instituted colonoscopic screening for family members where both parents had developed CRC compared the outcomes with other groups in our program.
3 Aim To compare screening outcomes screenees who have both parents affected with colorectal cancer, with moderate risk groups defined by Australian NHMRC criteria.
4 Methods Data on screening outcomes was derived from The Royal Melbourne Hospital (BCSP) and Southern Adelaide Health Services (SAHS) Bowel Cancer Screening Programs, who have been prospectively planning and documenting screening in familial bowel cancer for 29 and 16 years respectively. We evaluated the outcomes of the worst findings during screening in the patients stratified by density of family history of colorectal cancer and age of onset. Screening frequency was scheduled at 5 yearly intervals for all groups except those with HNPCC where screening was annual (gene carriers) or bi-ennial (Amsterdam positive, no mutation).
5 Definitions of Risk Groups: RELS A RELS B RELS C RELS D RELS E RELS F RELS G RELS H RELS Q RELS R RELS S CCC HNPCC Suspected HNPCC Definite Both parents with CRC Two siblings with CRC Parent + sibling with CRC Parent + grandparent with CRC One sibling and distant relative with CRC Parent and Parent's Sibling with CRC One 1 Relative with CRC <55 yr Identical twin with CRC Adenoma(s) in 1 o relative One 1 Relative >55 yr with CRC One or more CRC 2 or 3 Relative(s) with CRC More than two 1 st or second degree relatives (same side of the family) with CRCs. Age of onset (for all affecteds) >50 years More than One first degree relative with CRC or syndrome associated cancer with at least one affected 50 years of age or younger OR Three first degree relatives over two generations including at least one CRC and/or other syndromic cancer, all diagnosed over 50 years BUT Not Amsterdam I OR II Amsterdam II or II i.e. Three or more family members with CRC or syndromic cancers, at least one of whom is a first degree relative of the other two At least one affected at 50 years of age or younger Two generations affected OR MMR mutation in the family.
6 Collapsing of risk groups for analysis (see second figure) R0 R1 R2 R3 R4 No family history= Adenoma or Cancer Follow up RELS A,B,C,H (CRC Both Parents; CRC 2 Siblings; CRC Parent and sibling; CRC Twins) RELS D,E,F (CRC Parent and Grandparent; 1x 1 Relative +other family members with CRC; CRC Parent and Parent's Sibling) RELS G (CRC 1 Relative <55yr) RELS R,S,Q (CRC 1 Relative >55yr; CRC 2 or 3 Relative; Adenomas)
7 Results 83 screenees had a family history with both parents developing bowel cancer; In addition, there were 38 with 2 siblings affected with CRC, 105 with parent and sibling affected with CRC, 360 with one 1 st degree relative affected with CRC at <55years and 264 definite HNPCC (cancer-affected Amsterdam family members or MMR mutation positive individuals). Over the 30 year duration of our register, advanced adenomas or cancer occurred in 10.8% of the both parents group, compared with 18.4% in those with 2 siblings, 10.4% with a parent and sibling, 6.4% with parent and grandparent, and 10.2% for the group with a single 1 st relative affected under 55 years. In the definite HNPCC group who had annual or bi-ennial screening, advanced adenomas or cancer occurred in 13.7% of the cohort. In a logistic regression taking into account sex and age in addition to risk group, these differences were not statistically significantly different
8
9 Outcome at first worse colonoscopy by familial risk group
10 Results
11 Results
12 Conclusion Screening should be considered in families where both parents have developed CRC, regardless of age of onset of the cancer, as the outcome for advanced neoplasia is comparable to other established risk groups.
13 Acknowledgements With thanks to all the many generations of managers who have contributed to this information The RMH Bowel Cancer Surveillance Program is funded by donations of screenees and the public The merge and data analysis were funded through Australian BioGrid, with support from the Australian CSIRO and Victorian Government
Advice about familial aspects of breast cancer and epithelial ovarian cancer a guide for health professionals DECEMBER 2010
Advice about familial aspects of breast cancer and epithelial ovarian cancer a guide for health professionals DECEMBER 2010 This guide has three parts: 1. Information for health professionals 2. Tables
More informationRisk stratification for colorectal cancer especially: the difference between sporadic disease and polyposis syndromes. Dr. med. Henrik Csaba Horváth
Risk stratification for colorectal cancer especially: the difference between sporadic disease and polyposis syndromes Dr. med. Henrik Csaba Horváth Why is risk stratification for colorectal cancer (CRC)
More informationCommon Cancers & Hereditary Syndromes
Common Cancers & Hereditary Syndromes Elizabeth Hoodfar, MS, LCGC Regional Cancer Genetics Coordinator Kaiser Permanente Northern California Detect clinical characteristics of hereditary cancer syndromes.
More informationScreening guidelines tool
Screening guidelines tool Disclaimer: This material is intended as a general summary of screening and management recommendations; it is not intended to be comprehensive. Colorectal cancer (CRC) screening
More informationGenetics and Breast Cancer. Elly Lynch, Senior Genetic Counsellor Manager, Austin Health Clinical Genetics Service
Genetics and Breast Cancer Elly Lynch, Senior Genetic Counsellor Manager, Austin Health Clinical Genetics Service Overview Background/Our Team What is the difference between sporadic/familial cancer? How
More informationOverview of testing for Lynch syndrome/hnpcc
Overview of testing for Lynch syndrome/hnpcc This overview provides detailed information about interpreting MSI/IHC testing and genetic testing for Lynch syndrome/hnpcc. It is intended to be a reference
More informationGENETIC TESTING FOR INHERITED MUTATIONS OR SUSCEPTIBILITY TO CANCER OR OTHER CONDITIONS MED207.110
GENETIC TESTING FOR INHERITED MUTATIONS OR SUSCEPTIBILITY TO CANCER OR OTHER CONDITIONS MED207.110 COVERAGE: Pre- and post-genetic test counseling may be eligible for coverage in addition to the genetic
More informationNOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST NOTTINGHAM BREAST INSTITUTE BREAST AND OVARIAN FAMILY HISTORY GUIDELINES
NOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST NOTTINGHAM BREAST INSTITUTE BREAST AND OVARIAN FAMILY HISTORY GUIDELINES GP Referrals All GP referrals for asymptomatic women with a family history of breast and/or
More informationScreening for Bowel Cancer
Screening for Bowel Cancer Dr Bernard Ng, MBBS, FRANZCR Learning objectives What are the Risk factors for bowel cancer? What are the evidence-based screening tools available for low and high risk patients?
More informationGenetic Testing for Familial Adenomatous Polyposis and MYH-Associated Polyposis (Lynch Syndrome)
Harmony Behavioral Health, Inc. Harmony Behavioral Health of Florida, Inc. Harmony Health Plan of Illinois, Inc. HealthEase of Florida, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance
More informationOvarian Cancer Genetic Testing: Why, When, How?
Ovarian Cancer Genetic Testing: Why, When, How? Jeffrey Dungan, MD Associate Professor Division of Clinical Genetics Department of Obstetrics & Gynecology Northwestern University Feinberg School of Medicine
More informationScreening for Cancer in Light of New Guidelines and Controversies. Christopher Celio, MD St. Jude Heritage Medical Group
Screening for Cancer in Light of New Guidelines and Controversies Christopher Celio, MD St. Jude Heritage Medical Group Screening Tests The 2 major objectives of a good screening program are: (1) detection
More informationOF COLORECTAL CANCER
CHAPTER 6 SCREENING BASED ON FAMILY HISTORY OF COLORECTAL CANCER Interest in hereditary predisposition to Colorectal Cancer has increased greatly over the past 15 years, largely because of identification
More informationCancer Screening and Early Detection Guidelines
Cancer Screening and Early Detection Guidelines Guillermo Tortolero Luna, MD, PhD Director Cancer Control and Population Sciences Program University of Puerto Rico Comprehensive Cancer Center ASPPR Clinical
More informationCorporate Medical Policy Genetic Testing for Fanconi Anemia
Corporate Medical Policy Genetic Testing for Fanconi Anemia File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_fanconi_anemia 03/2015 3/2016 3/2017 3/2016 Description
More informationGynecologic Cancer in Women with Lynch Syndrome
Gynecologic Cancer in Women with Lynch Syndrome Sarah E. Ferguson, MD FRCSC Division of Gynecologic Oncology, Princess Margaret Hospital, University of Toronto June 11, 2013 Objective 1. To review the
More informationWORKSHOP DATES VICTORIA
VICTORIA 14 & 15 July 16 & 17 July 27 & 28 July 29 & 30 July 31 July Diploma 1 Day CAE Flinders Lane, Melbourne, 3000 31 August & 1 September 2 & 3 September 14 & 15 September 16 & 17 September 18 September
More informationHOW WILL SCREENING FOR GENETIC DISORDERS AFFECT LIFE INSURANCE?: A CASE STUDY OF COLORECTAL CANCER. By Angus Macdonald and Fei Yu.
1 HOW WILL SCREENING FOR GENETIC DISORDERS AFFECT LIFE INSURANCE?: A CASE STUDY OF COLORECTAL CANCER By Angus Macdonald and Fei Yu abstract Colorectal cancer (CRC) is a major cause of death. If CRC is
More informationUnderstanding Hereditary Breast and Ovarian Cancer. Maritime Hereditary Cancer Service
Understanding Hereditary Breast and Ovarian Cancer Maritime Hereditary Cancer Service General Information Cancer is very common. About one in three (33%) people are diagnosed with some form of cancer during
More informationThe Hereditary Colorectal Cancer Website has been sponsored by the Robert Rauschenberg Foundation
Introduction The Hereditary Colorectal Cancer Website has been sponsored by the Robert Rauschenberg Foundation Hereditary nonpolyposis colorectal cancer (HNPCC) syndrome was first described over 100 years
More informationValue-based healthcare in Lynch syndrome
Familial Cancer DOI 10.1007/s10689-013-9655-6 ORIGINAL ARTICLE Value-based healthcare in Lynch syndrome Simone D. Hennink Nandy Hofland Jessica P. Gopie Corinne van der Kaa Kimberley de Koning Maartje
More informationGenetic Testing for Lynch Syndrome/Colorectal Cancer and Polyposis Syndromes
Genetic Testing for Lynch Syndrome/Colorectal Cancer and Polyposis Syndromes Policy Number: Original Effective Date: MM.02.007 09/01/2011 Line(s) of Business: Current Effective Date: HMO; PPO 09/01/2011
More informationOffice of Population Health Genomics
Office of Population Health Genomics Policy: Protocol for the management of female BRCA mutation carriers in Western Australia Purpose: Best Practice guidelines for the management of female BRCA mutation
More informationUnderstanding genetic tests for Lynch syndrome. Information and decision aid
Understanding genetic tests for Lynch syndrome Information and decision aid This booklet was developed and printed with the support of: Hereditary Cancer Clinic, Prince of Wales Hospital Macquarie University
More informationThe Genetics of Early- Onset Breast Cancer. Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine
The Genetics of Early- Onset Breast Cancer Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine All cancers are genetic BUT Not all cancers are hereditary
More informationCOLORECTAL CANCER SCREENING
COLORECTAL CANCER SCREENING By Douglas K. Rex, M.D., FACG & Suthat Liangpunsakul, M.D. Division of Gastroenterology and Hepatology, Department of Medicine Indiana University School of Medicine Indianapolis,
More informationif your family has a history
if your family has a history OF CANCER. put it to the test. Learn about your risk for hereditary and ovarian and how you can reduce it. do you have a family history of Breast or Ovarian Cancer? what does
More informationColonoscopy Data Collection Form
Identifier: Sociodemographic Information Type: Zip Code: Gender: Height: (inches) Race: Ethnicity Inpatient Outpatient Male Female Birth Date: Weight: (pounds) American Indian (Native American) or Alaska
More informationScreening for colorectal cancer (CRC) in asymptomatic patients
GASTROENTEROLOGY 2012;143:844 857 Guidelines for Colonoscopy Surveillance After Screening and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer DAVID A. LIEBERMAN,*
More informationBreast Cancer Screening. Dr Jennifer Tan Radiologist Alfred Imaging BreastScreen SLHD, SWSLHD and GWNSW
Breast Cancer Screening Dr Jennifer Tan Radiologist Alfred Imaging BreastScreen SLHD, SWSLHD and GWNSW Learning Objectives Identify risk factors for breast cancer What to do with this information - GP
More informationColorectal Cancer: Preventable, Beatable, Treatable. American Cancer Society
Colorectal Cancer: Preventable, Beatable, Treatable American Cancer Society Reviewed January 2016 What we ll be talking about How common is colorectal cancer? What is colorectal cancer? What causes it?
More informationThe RCGP Curriculum: Clinical Modules
The RCGP Curriculum: Clinical Modules Version approved 18 May 2015 for implementation from 5 August 2015 3.02 Genetics in Primary Care Summary It has been estimated that at least one in ten of the patients
More informationGASTROENTEROLOGY 2006;130:1872 1885
GASTROENTEROLOGY 2006;130:1872 1885 Guidelines for Colonoscopy Surveillance After Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society
More informationEstimated new cancer cases U.S. 2011 U.S. 2011. Estimated cancer deaths
Colorectal Cancer Screening Estimated new cancer cases U.S. 2011 Estimated New Cases Sheryl Pfeil, MD Associate Professor of Clinical Medicine Division of Gastroenterology, Hepatology & Nutrition Ohio
More informationFamilial Breast Cancer Referrals and Risk Management
Familial Breast Cancer Referrals and Risk Management Presented by: Helen Mountain Genetic Counsellor Genetic Services of WA Perth (KEMH and PMH) Joondalup Rockingham Bunbury Geraldton Kalgoorlie Albany
More informationThe recommendations made throughout this book are by the National Health and Medical Research Council (NHMRC).
INTRODUCTION This book has been prepared for people with bowel cancer, their families and friends. The first section is for people with bowel cancer, and is intended to help you understand what bowel cancer
More informationColorectal Cancer: Preventable, Beatable, Treatable. American Cancer Society
Colorectal Cancer: Preventable, Beatable, Treatable American Cancer Society Reviewed January 2013 What we ll be talking about How common is colorectal cancer? What is colorectal cancer? What causes it?
More informationOregon Survey Instrument
Oregon Survey Instrument Cancer Genetic Insurance Questions for Insurers Q1a. Do you have written policies on your coverage of cancer genetic testing, counseling, and follow-up procedures for breast and
More informationCANCER RESEARCH UK STRATIFIED MEDICINE PROGRAMME IAN WALKER PHD, MBA HEAD OF STRATIFIED MEDICINE
CANCER RESEARCH UK STRATIFIED MEDICINE PROGRAMME IAN WALKER PHD, MBA HEAD OF STRATIFIED MEDICINE Agenda Introduction to Cancer Research UK CRUK Stratified Medicine Programme Key Challenges and Lessons
More informationHealth Policy Advisory Committee on Technology
Health Policy Advisory Committee on Technology Technology Overview Blood and stool biomarker testing for colorectal cancer screening July 2015 State of Queensland (Queensland Department of Health) 2015
More informationPrevention GENEration. The Importance of Genetic Testing for Hereditary Breast and Ovarian Cancer Syndrome (HBOC)
הסיכוי שבסיכון PREVENTION GENERATION Prevention GENEration The Importance of Genetic Testing for Hereditary Breast and Ovarian Cancer Syndrome (HBOC) We thank Prof. Ephrat Levy-Lahad Director, Medical
More informationPROSTATE CANCER SCREENING PROSTATE CANCER SCREENING
3:45 4:45pm Screening Guidelines for Men's Health SPEAKER Radha Rao, MD Presenter Disclosure Information The following relationships exist related to this presentation: Radha Rao, MD: No financial relationships
More informationRisk Assessment and Screening Tools November 17, 2010
Risk Assessment and Screening Tools November 17, 2010 Cecelia Bellcross Posted in the Resource Repository at: http://www.resourcerepository.org/documents/2073/riskassessmentandscreeningtool s/ Cecelia
More informationPatient Support Guide
Patient Support Guide to genetic testing for hereditary breast and ovarian cancer syndrome Testing for BRCA1 and BRCA2 is available from Quest Diagnostics. Quest Diagnostics Patient Support Guide to Genetic
More informationPopulation Genetics and Multifactorial Inheritance 2002
Population Genetics and Multifactorial Inheritance 2002 Consanguinity Genetic drift Founder effect Selection Mutation rate Polymorphism Balanced polymorphism Hardy-Weinberg Equilibrium Hardy-Weinberg Equilibrium
More informationClinical Indicator Ages 19-29 Ages 30-39 Ages 40-49 Ages 50-64 Ages 65+ Frequency of visit as recommended by PCP
SCREENING EXAMINATION & COUNSELING UPMC Health Plan Clinical Indicator Ages 19-29 Ages 30-39 Ages 40-49 Ages 50-64 Ages 65+ Annually Physical Exam and Counseling 1 Blood Pressure 2 At each visit. At least
More informationBioGrid s use of Business Analytics for Collaborative Medical Research. Maureen Turner, CEO, BioGrid Australia
BioGrid s use of Business Analytics for Collaborative Medical Research Maureen Turner, CEO, BioGrid Australia Overview Data sharing considerations BioGrid a collaborative model Data ethics, privacy, security
More informationUnderstanding Lynch Syndrome
ESSENTIALS Lynch Syndrome Understanding Lynch Syndrome Certain cancers can run in families. Sometimes this happens because of harmful changes (called mutations) in our genes that are passed from one generation
More informationTHE FINANCIAL IMPACT OF GENETIC INFORMATION ON THE INSURANCE INDUSTRY. By Fei (Billy) Yu
THE FINANCIAL IMPACT OF GENETIC INFORMATION ON THE INSURANCE INDUSTRY By Fei (Billy) Yu Submitted for the degree of Doctor of Philosophy on completion of research in the Department of Actuarial Mathematics
More informationBRCA in Men. Mary B. Daly,M.D.,Ph.D. June 25, 2010
BRCA in Men Mary B. Daly,M.D.,Ph.D. June 25, 2010 BRCA in Men Inheritance patterns of BRCA1/2 Cancer Risks for men with BRCA1/2 mutations Risk management recommendations for men with BRCA1/2 mutations
More informationNIH Public Access Author Manuscript Genet Med. Author manuscript; available in PMC 2009 August 13.
NIH Public Access Author Manuscript Published in final edited form as: Genet Med. 2006 September ; 8(9): 571 575. doi:10.1097/01.gim.0000237867.34011.12. Population-based study of the prevalence of family
More informationPrevention Checklist for Men
Page 1 of 5 Prevention Checklist for Men Great progress has been made in cancer research, but we still don t understand exactly what causes most cancers. We do know that many factors put us at higher risk
More informationTaking and Drawing a Family History
Taking and Drawing a Family History d. heart attack Ralph 1932 Beatrice 1932 3 Rachel 21/7/1952 type 2 diabetes Edward 18/11/1958 obese George 10/2/1955 Maureen 4/3/1958 Lily 9/1/1980 open wound on L foot
More information11/4/2014. Colon Cancer. Han Koh, MD Medical Oncology Downey Kaiser. 2 nd overall leading cause of cancer death in the United States.
Colon Cancer Han Koh, MD Medical Oncology Downey Kaiser 2 nd overall leading cause of cancer death in the United States 3 rd in each sex Approximately 6% of individuals in the US will develop a cancer
More informationDECURION : Descartes-Curie Model for Cancer Risks Assessment based on Family History
DECURION : Descartes-Curie Model for Cancer Risks Assessment based on Family History F. Alarcon(1), N. Belaribi(1), N. Andrieu(2), D. Stoppa-LyonnetG(3), Nuel(1). (1) MAP5 UMR CNRS 8145, (2) Inserm U900-Institut
More informationUnderstanding Your Risk of Ovarian Cancer
Understanding Your Risk of Ovarian Cancer A WOMAN S GUIDE This brochure is made possible through partnership support from Project Hope for Ovarian Cancer Research and Education. Project HOPE FOR OVARIAN
More informationThis fact sheet describes how genes affect our health when they follow a well understood pattern of genetic inheritance known as autosomal recessive.
11111 This fact sheet describes how genes affect our health when they follow a well understood pattern of genetic inheritance known as autosomal recessive. In summary Genes contain the instructions for
More informationThis publication was developed and produced with funding from the Centers for Disease Control and Prevention under a cooperative agreement.
This publication was developed and produced with funding from the Centers for Disease Control and Prevention under a cooperative agreement. Suggested Citation Centers for Disease Control and Prevention.
More informationHealth Check (Intellectual Disability)
Page 1 Health Check (Intellectual Disability) Use of a specific form to record the results of the health assessment is not mandatory but the health assessment should cover the matters listed below. The
More informationType 1 diabetes FACT SHEET 57
Important points Diabetes mellitus (diabetes) is a condition resulting in high levels of sugar (glucose) in the blood There are several types of diabetes: type 1 (insulin dependent diabetes), type 2 (non-insulin
More informationInequalities in Colon Cancer
Inequalities in Colon Cancer Chyke Doubeni, MD, FRCS, MPH Chair and The Presidential Associate Professor Department of Family Medicine and Community Health Perelman School of Medicine Senior Scholar, Center
More informationMendelian inheritance and the
Mendelian inheritance and the most common genetic diseases Cornelia Schubert, MD, University of Goettingen, Dept. Human Genetics EUPRIM-Net course Genetics, Immunology and Breeding Mangement German Primate
More informationGENETIC CONSIDERATIONS IN CANCER TREATMENT AND SURVIVORSHIP
GENETIC CONSIDERATIONS IN CANCER TREATMENT AND SURVIVORSHIP WHO IS AT HIGH RISK OF HEREDITARY CANCER? Hereditary Cancer accounts for a small proportion of all cancer or approximately 5-10% THE DEVELOPMENT
More informationGenetic Testing in Research & Healthcare
We Innovate Healthcare Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research and Healthcare Human genetic testing is a growing science. It is used to study genes
More informationHEREDITARY BRCA1. Faulty gene INFORMATION LEAFLET. How Do I Reduce My Risk?
HEREDITARY BREAST CANCER BRCA1 Faulty gene INFORMATION LEAFLET How Do I Reduce My Risk? Page 1 CONTENTS Part A 1 What is BRCA1 2 How does BRCA1 affect a person s risk of cancer? 3Testing for BRCA1 4Benefits
More informationD. Risk Status: All patients who are at average risk, increased risk, or in need of surveillance are eligible for direct screening services.
ANTHC CRCCP Policy No. 001 Page 1 of 3 ANTHC CRCCP ELIGIBILITY Purpose: To establish and define the ANTHC CRCCP eligibility criteria for direct screening services. Eligibility will be determined by patient
More informationFrequently Asked Questions About Ovarian Cancer
Media Contact: Gerri Gomez Howard Cell: 303-748-3933 gerri@gomezhowardgroup.com Frequently Asked Questions About Ovarian Cancer What is ovarian cancer? Ovarian cancer is a cancer that forms in tissues
More informationIntroduction to Pathology and Diagnostic Medicine
Harvard-MIT Division of Health Sciences and Technology HST.035: Principle and Practice of Human Pathology Dr. Badizadegan Introduction to Pathology and Diagnostic Medicine Spring 2003 What is pathology?
More informationColorectal Cancer Prevention and Early Detection
Colorectal Cancer Prevention and Early Detection What is colorectal cancer? Colorectal cancer is a term used to refer to cancer that develops in the colon or the rectum. These cancers are sometimes referred
More informationUNIVERSITY OF CALGARY. Post-Colorectal Cancer Screening: Knowledge and Understanding. Robin L. Walker A THESIS
UNIVERSITY OF CALGARY Post-Colorectal Cancer Screening: Knowledge and Understanding by Robin L. Walker A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL FULFILMENT OF THE REQUIREMENTS FOR
More informationGenetic conditions and insurance. What you need to know and what you need to tell
Genetic conditions and insurance What you need to know and what you need to tell About this booklet This information booklet has been produced to provide accessible and impartial information for people
More informationDevelopment of Advanced Healthcare Systems in Australia. Professor Stephen Smith Dean
Development of Advanced Healthcare Systems in Australia Professor Stephen Smith Dean 7 April 2014 Global Comparison (2012 Data) Australia Population (millions) 22.3 GDP (US$ billions) 1541.8 GDP per capita
More informationPreventive Care Guideline for Asymptomatic Low Risk Adults Age 18 through 64
Preventive Care Guideline for Asymptomatic Low Risk Adults Age 18 through 64 1. BMI - Documented in patients medical record on an annual basis. Screen for obesity and offer intensive counseling and behavioral
More informationCancer: Genetic testing can save lives
Cancer: Genetic testing can save lives Track chances of having a tumor's tendency among people with a history of disease cases in the family, but practice should not be trivialized and hurt even more who
More informationPosition Statement. Genetic Testing and Life Insurance in Australia
HUMAN GENETICS SOCIETY OF AUSTRALASIA ARBN. 076 130 937 (Incorporated Under the Associations Incorporation Act) The liability of members is limited PO Box 6012, Alexandria, NSW 2015 ABN No. 17 076 130
More informationCancer Expert Working Group on Cancer Prevention and Screening. Prevention and Screening for Colorectal Cancer
Cancer Expert Working Group on Cancer Prevention and Screening Prevention and Screening for Colorectal Cancer 1 What is colorectal cancer? Colorectum (colon and rectum, or the large bowel or large intestine)
More informationACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes
PRACTICE GUIDELINES nature publishing group 223 CME ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes Sapna Sy nga l, MD, M PH, FAC G 1, 2, 3, R and
More informationThe Department of Vermont Health Access Medical Policy
State of Vermont Department of Vermont Health Access 312 Hurricane Lane, Suite 201 [Phone] 802-879-5903 Williston, VT 05495-2807 [Fax] 802-879-5963 www.dvha.vermont.gov Agency of Human Services The Department
More informationOptional Tests Offered Before and During Pregnancy
Plano Women s Healthcare Optional Tests Offered Before and During Pregnancy Alpha-Fetoprotein Test (AFP) and Quad Screen These are screening tests that can assess your baby s risk of having such birth
More informationCompleteness of Physician Billing Claims for Diabetes Prevalence Estimation
Completeness of Physician Billing Claims for Diabetes Prevalence Estimation Lisa M. Lix 1, John Paul Kuwornu 1, George Kephart 2, Khokan Sikdar 3, Hude Quan 4 1 University of Manitoba; 2 Dalhousie University;
More informationDevelopment and Validation of a Colon Cancer Risk Assessment Tool for Patients Undergoing Colonoscopy
1508 ORIGINAL CONTRIBUTIONS nature publishing group Development and Validation of a Colon Cancer Risk Assessment Tool for Patients Undergoing Colonoscopy Fay Kast r inos, MD, MPH 1, 2, John I. A l len,
More informationWestern Australian Clinical Oncology Group RECOMMENDATIONS FOR SCREENING FOR SPECIFIC CANCERS: GUIDELINES FOR GENERAL PRACTITIONERS
Western Australian Clinical Oncology Group RECOMMENDATIONS FOR SCREENING FOR SPECIFIC CANCERS: GUIDELINES FOR GENERAL PRACTITIONERS Second Edition 2005 Western Australian Clinical Oncology Group RECOMMENDATIONS
More informationCase-control studies. Alfredo Morabia
Case-control studies Alfredo Morabia Division d épidémiologie Clinique, Département de médecine communautaire, HUG Alfredo.Morabia@hcuge.ch www.epidemiologie.ch Outline Case-control study Relation to cohort
More informationCurrent South Australian and Northern Territorian degrees and their relevance to the Class C ACT Builder s Licence reviewed November 2012
Current South and Northern Territorian degrees and their relevance to the Class C ACT Builder s Licence reviewed November 2012 Supported by: Building industry qualifications conducted by AQF Level Full
More informationBreast Cancer Screening
Breast Cancer Screening Summary of the Clinical Practice Guideline September 2013 These recommendations are systematically developed statements to assist practitioner and patient decisions about appropriate
More informationpatient guide BRCA1 and BRCA2 Genetic Testing for Hereditary Breast and Ovarian Cancer
patient guide BRCA1 and BRCA2 Genetic Testing for Hereditary Breast and Ovarian Cancer What is hereditary cancer? Cancer affects many people in the U.S.: breast cancer affects 1 in 8 women and ovarian
More informationColon Cancer Syndromes. Robin B. Mendelsohn MD Memorial Sloan Kettering Cancer Center Department of Medicine Gastroenterology and Nutrition Service
Colon Cancer Syndromes Robin B. Mendelsohn MD Memorial Sloan Kettering Cancer Center Department of Medicine Gastroenterology and Nutrition Service Background: Etiology of Colorectal Cancer (CRC) Sporadic:
More informationProvincial Quality Management Programs for Mammography, Colonoscopy and Pathology in Ontario
Provincial Quality Management Programs for Mammography, Colonoscopy and Pathology in Ontario Quality Management Partnership Consultation Materials: Heal th System Ad mi nistrato r s October 20, 2014 Table
More informationHow To Decide If You Should Get A Mammogram
American Medical Women s Association Position Paper on Principals of Breast Cancer Screening Breast cancer affects one woman in eight in the United States and is the most common cancer diagnosed in women
More informationGuidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer
nature publishing group PRACTICE GUIDELINES 1 see related editorial on page x s on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal
More informationMoving forward on bowel cancer screening in Australia
Moving forward on bowel cancer screening in Australia Report of a national discussion forum hosted by The Cancer Council Australia on 20 November 2006 and sponsored by the Australian Department of Health
More informationPaternity Testing. Chapter 23
Paternity Testing Chapter 23 Kinship and Paternity DNA analysis can also be used for: Kinship testing determining whether individuals are related Paternity testing determining the father of a child Missing
More informationAn Action Guide for Engaging Employers and Professional Medical Organizations
Increasing Quality Colorectal Cancer Screening and Promoting Screen Quality: An Action Guide for Engaging Employers and Professional Medical Organizations U.S. Department of Health and Human Services,
More informationBreast Cancer in the Family
Oxford University Hospitals NHS Trust Oxford Regional Genetic Department Breast Cancer in the Family Information for women with a moderately increased risk of breast cancer Breast cancer in the family
More informationElevated Risk of Prostate Cancer Among Men With Lynch Syndrome
Published Ahead of Print on March 25, 2013 as 10.1200/JCO.2012.44.1238 The latest version is at http://jco.ascopubs.org/cgi/doi/10.1200/jco.2012.44.1238 JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E
More informationCancer Prevention and Screening Hong Kong Perspective Professor TH LAM
Cancer Prevention and Screening Hong Kong Perspective Professor TH LAM Chairman, Cancer Expert Working Group on Prevention and Screening Chair Professor of Community Medicine, School of Public Health,
More informationHow To Know If You Are At Risk For Cancer
Ana Maria Lopez, MD, MPH, FACP Professor of Medicine and Pathology Arizona Cancer Center University of Arizona Definitions Rationale Who is at risk Guidelines Breast Cancer Colorectal Cancer Prostate Cancer
More informationpatient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015
patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015 BRCA1 and BRCA2 Mutations Cancer is a complex disease thought to be caused by several different factors. A few types of cancer
More informationEpi procolon The Blood Test for Colorectal Cancer Screening
Epi procolon The Blood Test for Colorectal Cancer Screening Epi procolon is an approved blood test for colorectal cancer screening. The US Preventive Services Task Force, the American Cancer Society and
More informationMarrying a relative. Is there an increased chance that a child will have genetic problems if its parents are related to each other?
Marrying a relative Is there an increased chance that a child will have genetic problems if its parents are related to each other? The simple answer to this question is Yes, there is an increased chance.
More information